|1.||Metka, Markus: 1 article (09/2003)|
|2.||Oettel, Michael: 1 article (09/2003)|
|3.||Saletu, Bernd: 1 article (09/2003)|
|4.||Huber, Johannes: 1 article (09/2003)|
|5.||Anderer, Peter: 1 article (09/2003)|
|6.||Gruber, Georg: 1 article (09/2003)|
|7.||Abu-Bakr, Manal Hassan: 1 article (09/2003)|
|8.||Gräser, Thomas: 1 article (09/2003)|
|9.||Mandl, Magdalena: 1 article (09/2003)|
|10.||Saletu-Zyhlarz, Gerda: 1 article (09/2003)|
|2.||Sleep Initiation and Maintenance Disorders (Insomnia)
08/01/2003 - "To determine the effects in postmenopausal women with insomnia of hormone replacement therapy (HRT) with 2 mg estradiol valerate (E2V) alone, or in combination with 3 mg dienogest (DNG), in the context of the introduction of the novel preparation Climodien (2 mg E2V/2 mg DNG) (Schering AG, Berlin, Germany). "
09/01/2003 - "Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone."
06/01/2000 - "A greater proportion of women in the Kliogest and E2Val 2/DNG 3 groups experienced vaginal bleeding, whereas breast problems were more common with Climodien. "
06/01/2000 - "Climodien appeared to be superior to Kliogest in terms of vaginal bleeding pattern, whereas E2Val 2/DNG 3 was associated with a slightly higher incidence and greater intensity of vaginal bleeding. "
|1.||dienogest drug combination estradiol Valerate
|5.||estradiol valerate (Delestrogen)
|1.||Hormone Replacement Therapy (Therapy, Hormone Replacement)